Inactivity-mediated insulin resistance is associated with upregulated pro-inflammatory fatty acids in human cell membranes

Clinical Nutrition

Volumn 29, Issue 3, 2010, Pages 386-390

  Mazzucco, Sara ^a   Agostini, Francesco ^a   Biolo, Gianni ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Desaturase; Fatty acids; Gas chromatography; Inflammation; Insulin resistance; Physical inactivity

Indexed keywords

ARACHIDONIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ACYL COENZYME A DESATURASE; AUTACOID; DELTA-5 FATTY ACID DESATURASE; DELTA-9 FATTY ACID DESATURASE; FATTY ACID; INSULIN; MONOUNSATURATED FATTY ACID;

ARTICLE; BED REST; BODY WEIGHT; CELL MEMBRANE; ERYTHROCYTE MEMBRANE; FOOD COMPOSITION; GAS CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMOBILIZATION; IMPEDANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; MALE; NORMAL HUMAN; UPREGULATION; BLOOD; BODY COMPOSITION; DIET; METABOLISM; PHYSIOLOGY; SEDENTARY LIFESTYLE; YOUNG ADULT;

ARACHIDONIC ACID; BED REST; BODY COMPOSITION; BODY WEIGHT; CELL MEMBRANE; DIET; ERYTHROCYTE MEMBRANE; FATTY ACID DESATURASES; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-6; HOMEOSTASIS; HUMANS; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; MALE; SEDENTARY LIFESTYLE; UP-REGULATION; YOUNG ADULT;

EID: 77953544839     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.09.006     Document Type: Article

References (25)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
2. Hamburg N.M., McMackin C.J., Huang A.L., Shenouda S.M., Widlansky M.E., Schulz E., et al. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol 2007, 27:2650-2656.
3. Bosutti A., Malaponte G., Zanetti M., Castellino P., Heer M., Guarnieri G., et al. Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. J Clin Endocrinol Metab 2008, 93:3226-3229.
4. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194. Review.
5. AlZadjali M.A., Godfrey V., Khan F., Choy A., Doney A.S., Wong A.K., et al. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 2009, 53:747-753.
6. Phinney S.D. Fatty acids, inflammation, and the metabolic syndrome. Am J Clin Nutr 2005, 82:1151-1152.
7. Das U.N. Metabolic syndrome X: an inflammatory condition?. Curr Hypertens Rep 2004, 6:66-73.
8. Vessby B., Gustafsson I.B., Tengblad S., Boberg M., Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 2002, 967:183-195.
9. Wallis J.G., Watts J.L., Browse J. Polyunsaturated fatty acid synthesis: what will they think of next?. Trends Biochem Sci 2002, 27:467.
10. Nigam A., Frasure-Smith N., Lespérance F., Julien P. Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome. Nutr Metab Cardiovasc Dis 2009, 19:264-270.
11. Warensjo E., Riserus U., Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005, 48:1999-2005.
12. Mimouni V., Poisson J.P. Altered desaturase activities and fatty acid composition in liver microsomes of spontaneously diabetic Wistar BB rat. Biochim Biophys Acta 1992, 1123:296-302.
13. Biolo G., Agostini F., Simunic B., Sturma M., Torelli L., Preiser J.C., et al. Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr 2008, 88:950-958.
14. Burdge G.C., Jones A.E., Wootton S.A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002, 88:355-363.
15. Luu N.T., Madden J., Calder P.C., Grimble R.F., Shearman C.P., Chan T., et al. Dietary supplementation with fish oil modifies the ability of human monocytes to induce an inflammatory response. J Nutr 2007, 137:2769-2774.
16. Borkman M., Storlien L.H., Pan D.A., Jenkins A.B., Chisholm D.J., Campbell L.V. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993, 328:238-244.
17. Andersson A., Sjödin A., Hedman A., Olsson R., Vessby B. Fatty acid profile of skeletal muscle phospholipids in trained and untrained young men. Am J Physiol Endocrinol Metab 2000, 279:744-751.
18. Helge J.W., Wu B.J., Willer M., Daugaard J.R., Storlien L.H., Kiens B. Training affects muscle phospholipid fatty acid composition in humans. J Appl Physiol 2001, 90:670-677.
19. Brenner R.R. Hormonal modulation of D6 and D5 desaturases: case of diabetes. Prostaglandins Leukot Essent Fatty Acids 2003, 68:151-162.
20. Ntambi J.M., Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res 2004, 43:91-104.
21. Peter A., Weigert C., Staiger H., Machicao F., Schick F., Machann J., et al. Individual stearoyl-CoA desaturase 1 (SCD1) expression modulates ER stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 2009, 28.
22. Helge J.W., Ayre K.J., Hulbert A.J., Kiens B., Storlien L.H. Regular exercise modulates muscle membrane phospholipid profile in rats. J Nutr 1999, 129:1636-1642.
23. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006, 83:1467S-1476S.
24. Conquer J.A., Holub B.J. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 1997, 32:341-345.
25. Gudbjarnason S. Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern Med Suppl 1989, 731:117-128.